Lifecore Biomedical Inc (LFCR)

Currency in USD
7.57
+0.01(+0.13%)
Closed·
7.570.00(0.00%)
·
LFCR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.447.91
52 wk Range
4.768.98
Key Statistics
Prev. Close
7.56
Open
7.67
Day's Range
7.44-7.91
52 wk Range
4.76-8.98
Volume
139.24K
Average Volume (3m)
157.69K
1-Year Change
28.088%
Book Value / Share
0.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LFCR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.25
Upside
+22.19%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Lifecore Biomedical Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Lifecore Biomedical Company Profile

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It offers services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Employees
406

Lifecore Biomedical Inc Earnings Call Summary for Q1/2026

  • Lifecore Biomedical exceeded Q3 2025 forecasts with EPS of -$0.29 vs -$0.32 expected and revenue of $31.1M vs $26.35M anticipated, representing 26% growth from the previous period.
  • The company improved its financial position by reducing net loss to $10M and achieving adjusted EBITDA of $3.1M, up from -$1.8M, despite a 2.22% stock decline after hours.
  • Management provided guidance for the transition period ending December 2025, projecting revenue between $74-76M and adjusted EBITDA of $12-14M.
  • CEO Paul Josephs highlighted the company's focus on top and bottom line growth, with 11 late-stage pipeline programs and significant commercial site transfer opportunities.
  • Lifecore expects a 45%/55% revenue split between first and second halves of 2026, with a major customer inflection point anticipated in 2027.
Last Updated: 06/11/2025, 22:24
Read Full Transcript

Compare LFCR to Peers and Sector

Metrics to compare
LFCR
Peers
Sector
Relationship
P/E Ratio
−6.4x1.2x−0.5x
PEG Ratio
0.01−0.330.00
Price/Book
212.3x2.3x2.6x
Price / LTM Sales
2.2x3.3x3.3x
Upside (Analyst Target)
22.2%15.1%45.8%
Fair Value Upside
Unlock4.1%6.4%Unlock

Analyst Ratings

2 Buy
3 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 9.25
(+22.19% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
KeyBanc
Hold---Maintain29/12/2025
KeyBanc
Hold---New Coverage04/09/2025
William Blair
Buy---New Coverage21/05/2025

Earnings

Latest Release
Jan 01, 2026
EPS / Forecast
-- / -0.1575
Revenue / Forecast
32.56M / 37.05M
EPS Revisions
Last 90 days

People Also Watch

65.49
CTBI
+2.06%
13.14
MPAA
+2.74%
45.28
CRNX
+1.09%
27.09
RAPP
+6.03%
25.85
NRIM
+2.05%

FAQ

What Is the Lifecore Biomedical (LFCR) Share Price Today?

The live Lifecore Biomedical share price today is 7.57

What Stock Exchange Does Lifecore Biomedical (LFCR) Trade On?

Lifecore Biomedical is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Lifecore Biomedical?

The stock symbol (also called a 'ticker') for Lifecore Biomedical is "LFCR."

What Is the Current Lifecore Biomedical Market Cap?

As of today, Lifecore Biomedical market capitalisation is 283.62M.

What Is Lifecore Biomedical's (LFCR) Earnings Per Share (TTM)?

The Lifecore Biomedical EPS is currently -1.27 (Trailing Twelve Months).

When Is the Next Lifecore Biomedical Earnings Date?

Lifecore Biomedical's next earnings report will be released on 01 Oct 2026.

Is LFCR a Buy or Sell From a Technical Analyst Perspective?

Based on today's Lifecore Biomedical moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Lifecore Biomedical Stock Split?

Lifecore Biomedical has split 0 times. (See the LFCR stock split history page for full effective split date and price information.)

How Many Employees Does Lifecore Biomedical Have?

Lifecore Biomedical has 406 employees.

What is the current trading status of Lifecore Biomedical (LFCR)?

As of 08 Feb 2026, Lifecore Biomedical (LFCR) is trading at a price of 7.57, with a previous close of 7.56. The stock has fluctuated within a day range of 7.44 to 7.91, while its 52-week range spans from 4.76 to 8.98.

What Is Lifecore Biomedical (LFCR) Price Target According to Analysts?

The average 12-month price target for Lifecore Biomedical is USD9.25, with a high estimate of USD10 and a low estimate of USD8.5. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +22.19% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.